Menopause Care Continuum Interactive Tool

A point-of-care snapshot of evidence-based information and key recommendations from the Society of Obstetricians and Gynaecologists of Canada (SOGC) Clinical Practice Guidelines across the menopause continuum. This tool visually outlines the clinical focus areas that health care providers should consider from perimenopause through late post-menopause to guide clinical and patient encounters.

How to use the tool

Use this tool as a set of quick prompts to guide your assessment, discussion, investigations and referrals when patients present with menopause-related symptoms or health concerns.

Links take you directly to the relevant SOGC Clinical Practice Guidelines.

The SOGC recognizes and respects the rights of all people for whom this information may apply, including but not limited to women, transgender, non-binary, and intersex people.

Stages of Menopause

Perimenopause:

The transitional phase leading up to menopause is often associated with clinical symptoms and changes in the menstrual cycle (early perimenopause ≥ 7 days variability in cycle length; late perimenopause: skipped cycles of 60 days or greater of amenorrhea). May begin around 40 years of age, but can be earlier.

Menopause may occur earlier due to genetic or medical conditions, such as premature ovarian insufficiency or surgical menopause following bilateral oophorectomy. In women with a hysterectomy, diagnosis relies on symptoms and, when needed, biochemical testing rather than bleeding patterns.

Menopause:

Defined as 12 consecutive months without a menstrual period. Typically ranges between 45 – 55 years.

Early post-menopause:

The first 10 years following menopause.

Late post-menopause:

11 or more years after menopause.

Source: SOGC Menopause Hub

Menopause Symptom Legend

Hover or click on a symptom for an overview.

Bone Health
Refers to osteoporosis risk and fractures due to decreased bone mineral density associated with hormonal changes in postmenopausal women.
Cardiovascular Health
Refers to the increased risk of cardiovascular disease associated with menopause, focusing on risk assessment and reduction in perimenopause, menopause, and post-menopause.
Mood, Sleep and Cognition
Refers to menopause-related changes in mood, anxiety, depression, sleep disturbances, memory, focus, and cognitive speed.
Menstrual Cycle
Refers to the changes in bleeding patterns and the eventual cessation of menstruation, marking menopause.
Genitourinary Health
Refers to the changes in vaginal and urinary tract tissues due to hormone deficiency (genitourinary syndrome of menopause, or GSM) that may cause dryness, discomfort, vaginal atrophy, dyspareunia, and urinary symptoms.
Vasomotor
Refers to hot flashes and night sweats caused by thermoregulatory changes, likely due to declining estrogen levels.
Sexual Health
Refers to changes in libido, dyspareunia, sexual desire, or orgasm that may occur during the menopausal transition.
Lifestyle Modifications
Refers to lifestyle factors such as balanced nutrition, regular weight-bearing exercise, vitamin D and calcium intake, smoking cessation, and limiting alcohol to support symptom management and long-term health.

Clinical Domains in Menopause Care

 

Perimenopause
Menopause
Early Post-Menopause
Late Post-Menopause

Bone Health:

  • Assess early fracture risk factors, including history, dietary calcium and vitamin D intake, and physical activity level. 
  • Reinforce weight-bearing exercise and a calcium enriched diet with adequate vitamin D supplementation to help maintain bone mineral density. 
  • Encourage smoking cessation and reduced alcohol consumption to prevent early bone loss.

 
Linked guideline: Guideline No. 422g: Menopause and Osteoporosis

Cardiovascular Health:

  • Monitor cardiovascular and metabolic disease risk factors.
  • Review prevention strategies related to elevated cardiovascular disease risk in premature or early menopause.
  • Encourage heart-healthy diet, physical activity, and lifestyle modifications to decrease cardiovascular disease risk where appropriate.
  • Counsel on the importance of smoking cessation and reduced alcohol consumption.

Linked guideline: Guideline No. 422e: Menopause and Cardiovascular Disease

Mood, Sleep and Cognition:

  • Ask about mood fluctuations, anxiety, sleep quality, memory and concentration concerns.
  • Screen for symptoms of anxiety and depression.
  • Provide counselling on sleep hygiene and rule out primary sleep disorders; manage vasomotor symptoms if they are affecting sleep.
    • Encourage women to trial other management modalities before considering the use of cannabis products for sleep.
  • Provide strategies for early lifestyle modifications that may help reduce the risk of cognitive decline.
  • Consider advising patients that there is no evidence to support cannabis use for the management of perimenopausal symptoms

Linked guidelines: Guideline No. 422c: Menopause: Mood, Sleep and Cognition; Guideline No. 425a: Cannabis Use Throughout Women’s Lifespans – Part 1: Fertility, Contraception, Menopause, and Pelvic Pain - Journal of Obstetrics and Gynaecology Canada

Genitourinary Health:

  • Provide information about the progressive impact of estrogen deficiency on urogenital health (such as vaginal dryness, irritation, impaired sexual function, or urinary symptoms [including urinary tract infection]) and the many options available for symptom relief.
  • Offer first-line management options for genitourinary syndrome of menopause; may include vaginal lubricants and/or vaginal moisturizers.

Linked guideline: Guideline No. 422b: Menopause and Genitourinary Health

Sexual Health:

  • Include a sexual screening history and physical examination in the initial evaluation, in patients with sexual concerns, as guided by clinical need/discussion.
  • Categorize symptoms as related to desire, arousal, pain, or orgasm, in order to facilitate treatment and to triage care.
  • Suggest vaginal estrogens, lubricants and moisturizers, and pharmacotherapies as treatments for vaginal atrophy related to menopause.

Linked guideline: Guideline No. 422d: Menopause and Sexuality

Lifestyle Modifications:

  • Encourage a healthy diet and lifestyle to reduce the risk of future chronic conditions, improve symptoms, aid in weight management, and improve energy levels.
  • Recommend a calcium-rich diet, adequate vitamin D, and increased vegetable intake.
  • Promote regular weight-bearing and aerobic exercise, smoking cessation, and reduced alcohol consumption.

Linked guidelines: Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle, Guideline No. 422c: Menopause: Mood, Sleep and Cognition, Guideline No. 422e: Menopause and Cardiovascular Disease, Guideline No. 422g: Menopause and Osteoporosis

Menstrual Cycle:

  • Document cycle length, regularity/variability, and bleeding heaviness.

Source: SOGC Menopause Hub

Vasomotor Symptoms:

  • Ask specifically about vasomotor symptoms (hot flashes and/or night sweats), including frequency and impact on quality of life.
  • Individualize management based on symptoms, medical conditions, health risks, family history, treatment goals, and patient preferences.
  • Reinforce lifestyle strategies (layering, cooling, stress management, sleep hygiene) and consider guideline-based therapeutic options when appropriate.

Linked guideline: Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle

Source: SOGC Menopause Hub

Bone Health:

  • Assess fracture risk factors, including history, dietary calcium and vitamin D intake, and physical activity level.
  • Reinforce weight-bearing exercise and a calcium-enriched diet with adequate vitamin D supplementation.
  • Reinforce smoking cessation and reduced alcohol consumption to prevent early bone loss.

Linked guideline: Guideline No. 422g: Menopause and Osteoporosis

Cardiovascular Health:

  • Monitor cardiovascular and metabolic disease risk factors.
  • Encourage diet and lifestyle modifications to decrease cardiovascular disease risk.
  • Reinforce smoking cessation and reduced alcohol consumption.

Linked guideline:Guideline No. 422e: Menopause and Cardiovascular Disease

Mood, Sleep and Cognition:

  • Ask about mood fluctuations, anxiety, sleep quality, memory and concentration concerns.
  • Screen for symptoms of anxiety and depression.
  • Provide counselling for poor sleep and rule out primary sleep disorders.
  • Provide counselling on lifestyle modifications that may help reduce the risk of cognitive decline.

Linked guideline:Guideline No. 422c: Menopause: Mood, Sleep and Cognition

Genitourinary Health:

  • Educate about the ongoing impact of estrogen deficiency on urogenital health (such as vaginal dryness, irritation, impaired sexual function, or urinary symptoms [including urinary tract infection]) and the many options available for symptom relief.
  • Screen for genitourinary syndrome of menopause (GSM) symptoms such as dryness, dyspareunia, or urinary frequency.

Linked guideline: Guideline No. 422b: Menopause and Genitourinary Health

Sexual Health:

  • Include a sexual screening history and physical examination in the initial evaluation, in patients with sexual concerns, as guided by clinical need/discussion.
  • Categorize concerns as related to desire, arousal, pain, or orgasm, in order to facilitate treatment and to triage care.
  • Advise on vaginal estrogens, lubricants and moisturizers, and pharmacotherapies as treatments for vaginal atrophy related to menopause.

Linked guideline: Guideline No. 422d: Menopause and Sexuality

Lifestyle Modifications:

  • Encourage diet and lifestyle modifications to help mitigate menopause-associated disease risk and symptoms.
  • Reinforce a calcium-rich diet, vitamin D supplementation, and increased vegetable intake.
    • Promote weight-bearing and aerobic exercise, smoking cessation, and reduced alcohol use.

Linked guidelines: Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle, Guideline No. 422c: Menopause: Mood, Sleep and Cognition, Guideline No. 422e: Menopause and Cardiovascular Disease, Guideline No. 422g: Menopause and Osteoporosis

Menstrual Cycle:

  • Confirm ≥12 months of amenorrhea before diagnosing menopause.
  • Any abnormal bleeding patterns or unscheduled bleeding should be investigated.

Source: SOGC Menopause Hub

Vasomotor Symptoms:

  • Ask about vasomotor symptoms (hot flashes and/or night sweats) and their impact on daily function and sleep.
  • Individualize management based on symptoms, medical conditions, health risks, family history, treatment goals, and patient preferences.

Linked guideline: Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle

Bone Health:

  • Screen for increased fracture risk by clinical evaluation and bone mineral density assessment.
  • Reinforce weight-bearing exercise and a calcium-enriched diet with adequate vitamin D supplementation.
  • Encourage smoking cessation and reduced alcohol consumption to prevent early bone loss.

Linked guideline: Guideline No. 422g: Menopause and Osteoporosis

Cardiovascular Health:

  • Monitor cardiovascular and metabolic disease risk factors.
  • Encourage diet and lifestyle modifications to decrease cardiovascular disease risk where appropriate.
  • Encourage smoking cessation and reduced alcohol consumption.

Linked guideline:Guideline No. 422e: Menopause and Cardiovascular Disease

Mood, Sleep and Cognition:

  • Ask about mood fluctuations, anxiety, sleep quality, memory and concentration concerns.
  • Screen for symptoms of anxiety and depression.
  • Provide counselling on sleep hygiene and rule out primary sleep disorders.
  • Address ongoing vasomotor symptoms that may be affecting sleep.
  • For cognitive concerns, encourage lifestyle modifications and assess for cognitive decline.

Linked guideline:Guideline No. 422c: Menopause: Mood, Sleep and Cognition

Genitourinary Health:

  • Screen for ongoing genitourinary syndrome of menopause (GSM) symptoms such as dryness, dyspareunia, or urinary frequency.

Linked guideline:Guideline No. 422b: Menopause and Genitourinary Health

Sexual Health:

  • Include a sexual screening history and physical examination in the initial evaluation, in patients with sexual concerns, as guided by clinical need/discussion.
  • Categorize complaints as related to desire, arousal, pain, or orgasm, in order to facilitate treatment and to triage care.
  • Address vaginal atrophy–related symptoms and biopsychosocial contributors.

Linked guideline: Guideline No. 422d: Menopause and Sexuality

Lifestyle Modifications:

  • Encourage diet and lifestyle modifications help mitigate postmenopausal disease risk and symptoms.
  • Reinforce calcium-rich diet, vitamin D, and increased vegetable intake.
  • Promote weight-bearing and aerobic exercise, smoking cessation, reduced alcohol consumption, and fall-prevention behaviours.

Linked guidelines: Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle, Guideline No. 422c: Menopause: Mood, Sleep and Cognition, Guideline No. 422e: Menopause and Cardiovascular Disease, Guideline No. 422g: Menopause and Osteoporosis,

Menstrual Cycle:

  • Confirm that no scheduled menstrual bleeding is expected.
  • Any abnormal bleeding patterns or unscheduled bleeding should be investigated.

Source: SOGC Menopause Hub

Vasomotor Symptoms:

  • Ask about ongoing vasomotor symptoms (hot flashes and/or night sweats) and their impact.
  • Individualize management based on symptoms, medical conditions, health risks, family history, treatment goals, and patient preferences.

Linked guideline: Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle

Bone Health:

  • Screen for increased fracture risk by clinical evaluation, bone mineral density assessment, and assessment of fall risk.
  • Continue to reinforce weight-bearing exercise, as well as a calcium-enriched diet with adequate vitamin D supplementation. Encourage smoking cessation and reduced alcohol consumption to prevent early bone loss.

Linked guideline: Guideline No. 422g: Menopause and Osteoporosis

Cardiovascular Health:

  • Monitor cardiovascular and metabolic disease risk factors.
  • Reinforce diet and lifestyle modifications to decrease cardiovascular disease risk where appropriate.
  • Encourage smoking cessation and reduced alcohol consumption.

Linked guideline:Guideline No. 422e: Menopause and Cardiovascular Disease

Mood, Sleep and Cognition:

  • Ask about mood fluctuations, anxiety, sleep quality, memory and concentration concerns.
  • Screen for symptoms of anxiety and depression.
    • Address sleep issues with sleep hygiene education and evaluation for primary sleep disorders.
  • For cognitive complaints, encourage lifestyle modifications to decrease the risk of cognitive decline
    • Assess for cognitive decline and investigate potential causes

Linked guideline:Guideline No. 422c: Menopause: Mood, Sleep and Cognition

Genitourinary Health:

  • Screen for ongoing symptoms of genitourinary symptoms, such as dryness, dyspareunia, or urinary frequency.

Linked guideline:Guideline No. 422b: Menopause and Genitourinary Health

Sexual Health:

  • Include a sexual screening history and physical examination in the initial evaluation, in patients with sexual concerns, as guided by clinical need/discussion.
  • Categorize complaints as related to desire, arousal, pain, or orgasm, in order to facilitate treatment and to triage care.

Linked guideline: Guideline No. 422d: Menopause and Sexuality

Lifestyle Modifications:

  • Reinforce diet and lifestyle modifications to help mitigate postmenopausal disease risk and symptoms.
  • Encourage a calcium-rich diet, vitamin D supplementation, and increased vegetable intake.
  • Promote weight-bearing and aerobic exercise, smoking cessation, and reduced alcohol use.

Linked guidelines: Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle, Guideline No. 422c: Menopause: Mood, Sleep and Cognition, Guideline No. 422e: Menopause and Cardiovascular Disease, Guideline No. 422g: Menopause and Osteoporosis

Menstrual Cycle:

  • Recognize that scheduled menstrual bleeding is not expected.
  • Investigate any abnormal bleeding patterns or unscheduled bleeding.

Source: SOGC Menopause Hub

Vasomotor Symptoms:

  • Ask about ongoing vasomotor symptoms (hot flashes and/or night sweats) and their impact on function and quality of life.

Linked guideline: Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle

The Society of Obstetricians and Gynaecologists of Canada (SOGC)